Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - olopatadine hydrochloride, quantity: 665 microgram/actuation (equivalent: olopatadine, qty 600 microgram/actuation); mometasone furoate monohydrate, quantity: 25.86 microgram/actuation (equivalent: mometasone furoate, qty 25 microgram/actuation) - spray, nasal - excipient ingredients: sodium chloride; hydrochloric acid; carmellose sodium; sodium hydroxide; dibasic sodium phosphate heptahydrate; dispersible cellulose; benzalkonium chloride; water for injections; polysorbate 80; disodium edetate - ryaltris is indicated for the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - fluticasone propionate, quantity: 50 microgram/actuation; azelastine hydrochloride, quantity: 137 microgram/actuation (equivalent: azelastine, qty 125 microgram/actuation) - spray, nasal - excipient ingredients: phenethyl alcohol; benzalkonium chloride; purified water; microcrystalline cellulose; polysorbate 80; carmellose sodium; glycerol; disodium edetate - symptomatic treatment of moderate to severe allergic rhinitis for up to 6 months.

Malta - angličtina - Medicines Authority

kleva s.a. 189 parnithos avenue, 13671 acharnai, attiki, greece - budesonide - nasal spray, suspension - budesonide 100 µg - nasal preparations

Malta - angličtina - Medicines Authority

cipla (eu) limited hillbrow house, hillbrow road, esher, surrey, kt10 9nw, united kingdom - mometasone furoate - nasal spray, suspension - mometasone furoate 50 µg - nasal preparations

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - azelastine hydrochloride, quantity: 0.137 mg/actuation (equivalent: azelastine, qty 0.125 mg/actuation) - spray, nasal - excipient ingredients: dibasic sodium phosphate dodecahydrate; disodium edetate; hypromellose; purified water; citric acid; sodium chloride - for the symptomatic treatment of seasonal allergic rhinitis, perennial allergic rhinitis.

Spojené kráľovstvo - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

haleon uk ltd - fluticasone propionate - spray - 50microgram/1dose

Spojené kráľovstvo - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

haleon uk ltd - fluticasone propionate - spray - 50microgram/1dose

Malta - angličtina - Medicines Authority

xantis pharma limited lemesou, 5 eurosure tower, 1st floor, flat/office 101, 2112, nicosia, cyprus - azelastine hydrochloride - nasal spray, solution - azelastine hydrochloride 0.14 mg - nasal preparations

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - nafarelin, quantity: 2 mg/ml - spray, solution - excipient ingredients: benzalkonium chloride; sorbitol; glacial acetic acid; hydrochloric acid; purified water; sodium hydroxide - indications as at 31 august 1995. synarel is indicated for the hormonal management of visually proven endometriosis, including pain relief and reduction of endometriotic lesions and for use in controlled ovarian stimulation programmes prior to in-vitro fertilisation, under the supervision of an infertility specialist.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - naloxone hydrochloride dihydrate, quantity: 2.2 mg/actuation - spray, nasal - excipient ingredients: sodium chloride; hydrochloric acid; sodium citrate dihydrate; nitrogen; sodium hydroxide; purified water - nyxoid is intended as part of the emergency treatment for known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression in:,? the home or other non medical setting,? a health facility setting,for this reason, nyxoid should be carried by persons at risk of, or likely to witness such events.,nyxoid is indicated in adults and children.